Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 11, 2019
Vertiflex acquisition adds the only FDA-approved, commercially available, minimally invasive interspinous spacer to Boston Scientific’s chronic pain portfolio.
-
May 22, 2019Findings could expand number of patients who can receive alternative treatment to life-long use of blood thinners
WATCHMAN device findings could expand number of non-valvular atrial fibrillation (AFib) patients who can receive alternative treatment to lifelong use of blood thinners.
-
May 10, 2019New data further support use of S-ICD System as first-line therapy for majority of ICD patients
New clinical trial data further support use of Boston Scientific’s EMBLEM S-ICD System as first-line therapy for majority of ICD patients.
-
May 9, 2019Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies.
-
May 6, 2019New stent system now available for treating patients with deep venous blockages
New stent system now available for treating patients with deep venous blockages.
-
Apr 24, 2019
"With our strong pipeline and category leadership strategy, we are confident in our top tier 2019 outlook,” said CEO Mike Mahoney. Read the April 2019 release.
-
Apr 23, 2019Transcatheter Aortic Valve Replacement Technology for Patients with Severe Aortic Stenosis Designed to Minimize Paravalvular Leakage, Offer Controlled Delivery and Repositionability Post Deployment
Transcatheter aortic valve replacement technology for patients with severe aortic stenosis designed to minimize paravalvular leakage, offer controlled delivery and repositionability post deployment.
-
Mar 17, 2019New data showcasing performance of recently acquired RF balloon-based, single-shot ablation technology
New data showcases safety & efficacy of recently acquired RF balloon-based, single-shot ablation technology when treating patients with AFib.
-
Mar 13, 2019Company begins limited market release in Europe
Company begins limited market release in Europe for next generation WATCHMAN device, intended to reduce the risk of stroke in people with non-valvular AFib.
-
Feb 28, 2019
Solutions for nutrition support and early detection of respiratory issues win and place at Connected Patient Challenge competition focused on chronic conditions.